RIG-I-like receptors and negative-strand RNA viruses: RLRly bird catches some worms

Cytokine and Growth Factor Reviews

Volumn 25, Issue 5, 2014, Pages 621-628

  Weber, Michaela ^a   Weber, Friedemann ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Genome segmentation; Negative strand RNA virus; Panhandle; RIG I like receptors; Viral countermeasures

Indexed keywords

GENOMIC RNA; RECEPTOR; RIG I LIKE RECEPTOR; RNA HELICASE; SINGLE STRANDED RNA; UNCLASSIFIED DRUG; DDX58 PROTEIN, HUMAN; DEAD BOX PROTEIN;

GENETIC ANALYSIS; GENETIC PARAMETERS; GENOME SEGMENTATION; HUMAN; INNATE IMMUNITY; LIGAND BINDING; MOLECULAR RECOGNITION; NEGATIVE STRAND RNA VIRUS; NONHUMAN; PROMOTER REGION; PROTEIN RNA BINDING; PROTEIN STRUCTURE; RECEPTOR UPREGULATION; RNA STRUCTURE; RNA VIRUS; SHORT SURVEY; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION; VIRUS GENOME; ANIMAL; GENETICS; IMMUNOLOGY; METABOLISM; PROTEIN TERTIARY STRUCTURE;

ANIMALS; DEAD-BOX RNA HELICASES; GENOME, VIRAL; HUMANS; IMMUNITY, INNATE; PROTEIN STRUCTURE, TERTIARY; RNA VIRUSES; SIGNAL TRANSDUCTION;

EID: 84908353501     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2014.05.004     Document Type: Short Survey

References (119)

1. Moya A., Elena S.F., Bracho A., Miralles R., Barrio E. The evolution of RNA viruses: a population genetics view. Proc Natl Acad Sci U S A 2000, 97:6967-6973.
2. Belgnaoui S.M., Paz S., Hiscott J. Orchestrating the interferon antiviral response through the mitochondrial antiviral signaling (MAVS) adapter. Curr Opin Immunol 2011, 23:564-572.
3. Eifan S., Schnettler E., Dietrich I., Kohl A., Blomstrom A.L. Non-structural proteins of arthropod-borne bunyaviruses: roles and functions. Viruses 2013, 5:2447-2468.
4. Gack M.U. Mechanisms of RIG-I-like receptor activation and manipulation by viral pathogens. J Virol 2014, 88:5213-5216.
5. Garcia-Sastre A. Induction and evasion of type I interferon responses by influenza viruses. Virus Res 2011, 162:12-18.
6. Gerlier D., Lyles D.S. Interplay between innate immunity and negative-strand RNA viruses: towards a rational model. Microbiol Mol Biol Rev MMBR 2011, 75:468-490. [second page of table of contents].
7. Goubau D., Deddouche S., Reis e Sousa C. Cytosolic sensing of viruses. Immunity 2013, 38:855-869.
8. Hale B.G., Randall R.E., Ortin J., Jackson D. The multifunctional NS1 protein of influenza A viruses. J Gen Virol 2008, 89:2359-2376.
9. Kolakofsky D., Kowalinski E., Cusack S. A structure-based model of RIG-I activation. RNA 2012, 18:2118-2127.
10. Ng C.S., Kato H., Fujita T. Recognition of viruses in the cytoplasm by RLRs and other helicases - how conformational changes, mitochondrial dynamics and ubiquitination control innate immune responses. Int Immunol 2012, 24:739-749.
11. Parks G.D., Alexander-Miller M.A. Paramyxovirus activation and inhibition of innate immune responses. J Mol Biol 2013, 425:4872-4892.
12. Schoggins J.W., Rice C.M. Interferon-stimulated genes and their antiviral effector functions. Curr Opin Virol 2011, 1:519-525.
13. Schlee M. Master sensors of pathogenic RNA - RIG-I like receptors. Immunobiology 2013, 218:1322-1335.
14. Zinzula L., Tramontano E. Strategies of highly pathogenic RNA viruses to block dsRNA detection by RIG-I-like receptors: hide, mask, hit. Antiviral Res 2013, 100:615-635.
15. Kohlway A., Luo D., Rawling D.C., Ding S.C., Pyle A.M. Defining the functional determinants for RNA surveillance by RIG-I. EMBO Rep 2013, 14:772-779.
16. Kowalinski E., Lunardi T., McCarthy A.A., Louber J., Brunel J., Grigorov B., et al. Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA. Cell 2011, 147:423-435.
17. Childs K.S., Randall R.E., Goodbourn S. LGP2 plays a critical role in sensitizing MDA-5 to activation by double-stranded RNA. PLoS ONE 2013, 8:e64202.
18. Satoh T., Kato H., Kumagai Y., Yoneyama M., Sato S., Matsushita K., et al. LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses. Proc Natl Acad Sci U S A 2010, 107:1512-1517.
19. Gack M.U., Shin Y.C., Joo C.H., Urano T., Liang C., Sun L., et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 2007, 446:916-920.
20. Patel J.R., Jain A., Chou Y.Y., Baum A., Ha T., Garcia-Sastre A. ATPase-driven oligomerization of RIG-I on RNA allows optimal activation of type-I interferon. EMBO Rep 2013, 14:780-787.
21. Peisley A., Wu B., Xu H., Chen Z.J., Hur S. Structural basis for ubiquitin-mediated antiviral signal activation by RIG-I. Nature 2014.
22. Wies E., Wang M.K., Maharaj N.P., Chen K., Zhou S., Finberg R.W., et al. Dephosphorylation of the RNA sensors RIG-I and MDA5 by the phosphatase PP1 is essential for innate immune signaling. Immunity 2013, 38:437-449.
23. Zeng W.W., Sun L.J., Jiang X.M., Chen X., Hou F.J., Adhikari A., et al. Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell 2010, 141:315-330.
24. Binder M., Eberle F., Seitz S., Mucke N., Huber C.M., Kiani N., et al. Molecular mechanism of signal perception and integration by the innate immune sensor retinoic acid-inducible Gene-I (RIG-I). J Biol Chem 2011, 286:27278-27287.
25. Wu B., Peisley A., Richards C., Yao H., Zeng X., Lin C., et al. Structural basis for dsRNA recognition, filament formation, and antiviral signal activation by MDA5. Cell 2013, 152:276-289.
26. Schlee M., Roth A., Hornung V., Hagmann C.A., Wimmenauer V., Barchet W., et al. Recognition of 5' triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity 2009, 31:25-34.
27. Schmidt A., Schwerd T., Hamm W., Hellmuth J.C., Cui S., Wenzel M., et al. 5'-Triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I. Proc Natl Acad Sci U S A 2009, 106:12067-12072.
28. Kato H., Takeuchi O., Mikamo-Satoh E., Hirai R., Kawai T., Matsushita K., et al. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med 2008, 205:1601-1610.
29. Malathi K., Saito T., Crochet N., Barton D.J., Gale M., Silverman R.H., Nase R. L releases a small RNA from HCV RNA that refolds into a potent PAMP. RNA 2010, 16:2108-2119.
30. Saito T., Owen D.M., Jiang F., Marcotrigiano J., Gale M. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 2008, 454:523-527.
31. Pichlmair A., Schulz O., Tan C.P., Rehwinkel J., Kato H., Takeuchi O., et al. Activation of MDA5 requires higher-order RNA structures generated during virus infection. J Virol 2009, 83:10761-10769.
32. Luthra P., Sun D., Silverman R.H., He B. Activation of IFN-beta expression by a viral mRNA through RNase L and MDA5. Proc Natl Acad Sci U S A 2011, 108:2118-2123.
33. Runge S., Sparrer K.M., Lassig C., Hembach K., Baum A., Garcia-Sastre A., et al. In vivo ligands of MDA5 and RIG-I in measles virus-infected cells. PLoS Pathogens 2014, 10:e1004081.
34. Davis W.G., Bowzard J.B., Sharma S.D., Wiens M.E., Ranjan P., Gangappa S., et al. The 3' untranslated regions of influenza genomic sequences are 5'ppp-independent ligands for RIG-I. PLoS ONE 2012, 7:e32661.
35. Ruigrok R.W., Crepin T., Kolakofsky D. Nucleoproteins and nucleocapsids of negative-strand RNA viruses. Curr Opin Microbiol 2011, 14:504-510.
36. Weber F., Wagner V., Rasmussen S.B., Hartmann R., Paludan S.R. Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J Virol 2006, 80:5059-5064.
37. Weber M., Gawanbacht A., Habjan M., Rang A., Borner C., Schmidt A.M., et al. Incoming RNA virus nucleocapsids containing a 5'-triphosphorylated genome activate RIG-I and antiviral signaling. Cell Host Microbe 2013, 13:336-346.
38. Baum A., Sachidanandam R., Garcia-Sastre A. Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing. Proc Natl Acad Sci U S AV 107 2010, 16303-16308.
39. Bitko V., Musiyenko A., Bayfield M.A., Maraia R.J., Barik S. Cellular La protein shields nonsegmented negative-strand RNA viral leader RNA from RIG-I and enhances virus growth by diverse mechanisms. J Virol 2008, 82:7977-7987.
40. Ikegame S., Takeda M., Ohno S., Nakatsu Y., Nakanishi Y., Yanagi Y. Both RIG-I and MDA5 RNA helicases contribute to the induction of alpha/beta interferon in measles virus-infected human cells. J Virol 2010, 84:372-379.
41. Plumet S., Herschke F., Bourhis J.M., Valentin H., Longhi S., Gerlier D. Cytosolic 5'-triphosphate ended viral leader transcript of measles virus as activator of the RIG I-mediated interferon response. PLoS ONE 2007, 2:e279.
42. Perrault J. Origin and replication of defective interfering particles. Curr Top Microbiol Immunol 1981, 93:151-207.
43. Strahle L., Garcin D., Kolakofsky D. Sendai virus defective-interfering genomes and the activation of interferon-beta. Virology 2006, 351:101-111.
44. Killip M.J., Smith M., Jackson D., Randall R.E. Activation of the interferon induction cascade by influenza a viruses requires viral RNA synthesis and nuclear export. J Virol 2014, 88:3942-3952.
45. Perez-Cidoncha M., Killip M.J., Oliveros J.C., Asensio V.J., Fernandez Y., Bengoechea J.A., et al. An unbiased genetic screen reveals the polygenic nature of the influenza virus anti-interferon response. J Virol 2014, 88:4632-4646.
46. Rehwinkel J., Tan C.P., Goubau D., Schulz O., Pichlmair A., Bier K., et al. RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 2010, 140:397-408.
47. Briese T., Calisher C.H., Higgs S. Viruses of the family Bunyaviridae: are all available isolates reassortants?. Virology 2013, 446:207-216.
48. Pressing J., Reanney D.C. Divided genomes and intrinsic noise. J Mol Evolution 1984, 20:135-146.
49. Ojosnegros S., Garcia-Arriaza J., Escarmis C., Manrubia S.C., Perales C., Arias A., et al. Viral genome segmentation can result from a trade-off between genetic content and particle stability. PLoS Genetics 2011, 7:e1001344.
50. Kawaguchi A., Momose F., Nagata K. Replication-coupled and host factor-mediated encapsidation of the influenza virus genome by viral nucleoprotein. J Virol 2011, 85:6197-6204.
51. Wisskirchen C., Ludersdorfer T.H., Muller D.A., Moritz E., Pavlovic J. The cellular RNA helicase UAP56 is required for prevention of double-stranded RNA formation during influenza A virus infection. J Virol 2011, 85:8646-8655.
52. Boonyaratanakornkit J., Bartlett E., Schomacker H., Surman S., Akira S., Bae Y.S., et al. The C proteins of human parainfluenza virus type 1 limit double-stranded RNA accumulation that would otherwise trigger activation of MDA5 and protein kinase R. J Virol 2011, 85:1495-1506.
53. Dillon P.J., Parks G.D. Role for the phosphoprotein P subunit of the paramyxovirus polymerase in limiting induction of host cell antiviral responses. J Virol 2007, 81:11116-11127.
54. Manuse M.J., Parks G.D. Role for the paramyxovirus genomic promoter in limiting host cell antiviral responses and cell killing. J Virol 2009, 83:9057-9067.
55. Nakatsu Y., Takeda M., Ohno S., Koga R., Yanagi Y. Translational inhibition and increased interferon induction in cells infected with C protein-deficient measles virus. J Virol 2006, 80:11861-11867.
56. Pfaller C.K., Radeke M.J., Cattaneo R., Samuel C.E. Measles virus C protein impairs production of defective copyback double-stranded viral RNA and activation of protein kinase R. J Virol 2014, 88:456-468.
57. Takeuchi K., Komatsu T., Kitagawa Y., Sada K., Gotoh B. Sendai virus C protein plays a role in restricting PKR activation by limiting the generation of intracellular double-stranded RNA. J Virol 2008, 82:10102-10110.
58. Osterlund P., Strengell M., Sarin L.P., Poranen M.M., Fagerlund R., Melen K., et al. Incoming influenza A virus evades early host recognition, while influenza B virus induces interferon expression directly upon entry. J Virol 2012, 86:11183-11193.
59. Hatada E., Fukuda R. Binding of influenza A virus NS1 protein to dsRNA in vitro. J Gen Virol 1992, 73(Pt 12):3325-3329.
60. Ramanan P., Edwards M.R., Shabman R.S., Leung D.W., Endlich-Frazier A.C., Borek D.M., et al. Structural basis for Marburg virus VP35-mediated immune evasion mechanisms. Proc Natl Acad Sci U S A 2012, 109:20661-20666.
61. Kimberlin C.R., Bornholdt Z.A., Li S., Woods V.L., MacRae I.J., Saphire E.O. Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression. Proc Natl Acad Sci U S A 2010, 107:314-319.
62. Qian X.Y., Chien C.Y., Lu Y., Montelione G.T., Krug R.M. An amino-terminal polypeptide fragment of the influenza virus NS1 protein possesses specific RNA-binding activity and largely helical backbone structure. RNA 1995, 1:948-956.
63. Gack M.U., Albrecht R.A., Urano T., Inn K.S., Huang I.C., Carnero E., et al. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 2009, 5:439-449.
64. Luthra P., Ramanan P., Mire C.E., Weisend C., Tsuda Y., Yen B., et al. Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome. Cell Host Microbe 2013, 14:74-84.
65. Noah D.L., Twu K.Y., Krug R.M. Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3' end processing of cellular pre-mRNAS. Virology 2003, 307:386-395.
66. Prins K.C., Cardenas W.B., Basler C.F. Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1. J Virol 2009, 83:3069-3077.
67. Habjan M., Andersson I., Klingstrom J., Schumann M., Martin A., Zimmermann P., et al. Processing of genome 5' termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS ONE 2008, 3:e2032.
68. Wang H., Vaheri A., Weber F., Plyusnin A. Old world hantaviruses do not produce detectable amounts of dsRNA in infected cells and the 5' termini of their genomic RNAs are monophosphorylated. J Gen Virol 2011, 92:1199-1204.
69. Lee M.H., Lalwani P., Raftery M.J., Matthaei M., Lutteke N., Kirsanovs S., et al. RNA helicase retinoic acid-inducible gene I as a sensor of Hantaan virus replication. J Gen Virol 2011, 92:2191-2200.
70. Albarino C.G., Bergeron E., Erickson B.R., Khristova M.L., Rollin P.E., Nichol S.T. Efficient reverse genetics generation of infectious junin viruses differing in glycoprotein processing. J Virol 2009, 83:5606-5614.
71. Marq J.B., Hausmann S., Veillard N., Kolakofsky D., Garcin D. Short double-stranded RNAs with an overhanging 5'ppp-nucleotide, as found in arenavirus genomes, act as RIG-I decoys. J Biol Chem 2011, 286:6108-6116.
72. Hastie K.M., Kimberlin C.R., Zandonatti M.A., MacRae I.J., Saphire E.O. Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3' to 5' exonuclease activity essential for immune suppression. Proc Natl Acad Sci U S A 2011, 108:2396-2401.
73. Qi X., Lan S., Wang W., Schelde L.M., Dong H., Wallat G.D., et al. Cap binding and immune evasion revealed by Lassa nucleoprotein structure. Nature 2010, 468:779-783.
74. Fan L., Briese T., Lipkin W.I. Z proteins of New World arenaviruses bind RIG-I and interfere with type I interferon induction. J Virol 2010, 84:1785-1791.
75. Ling Z., Tran K.C., Teng M.N. Human respiratory syncytial virus nonstructural protein NS2 antagonizes the activation of beta interferon transcription by interacting with RIG-I. J Virol 2009, 83:3734-3742.
76. Frias-Staheli N., Giannakopoulos N.V., Kikkert M., Taylor S.L., Bridgen A., Paragas J., et al. Ovarian tumor domain-containing viral proteases evade ubiquitin- and ISG15-dependent innate immune responses. Cell Host Microbe 2007, 2:404-416.
77. van Kasteren P.B., Beugeling C., Ninaber D.K., Frias-Staheli N., van Boheemen S., Garcia-Sastre A., et al. Arterivirus and nairovirus ovarian tumor domain-containing Deubiquitinases target activated RIG-I to control innate immune signaling. J Virol 2012, 86:773-785.
78. Andrejeva J., Childs K.S., Young D.F., Carlos T.S., Stock N., Goodbourn S., et al. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci U S A 2004, 101:17264-17269.
79. Motz C., Schuhmann K.M., Kirchhofer A., Moldt M., Witte G., Conzelmann K.K., et al. Paramyxovirus V proteins disrupt the fold of the RNA sensor MDA5 to inhibit antiviral signaling. Science 2013, 339:690-693.
80. Childs K., Randall R., Goodbourn S., Paramyxovirus V. proteins interact with the RNA helicase LGP2 to inhibit RIG-I-dependent interferon induction. J Virol 2012, 86:3411-3421.
81. Chen W., Han C., Xie B., Hu X., Yu Q., Shi L., et al. Induction of Siglec-G by RNA viruses inhibits the innate immune response by promoting RIG-I degradation. Cell 2013, 152:467-478.
82. Gori-Savellini G., Valentini M., Cusi M.G. Toscana virus NSs protein inhibits the induction of type I interferon by interacting with RIG-I. J Virol 2013, 87:6660-6667.
83. Lifland A.W., Jung J., Alonas E., Zurla C., Crowe J.E., Santangelo P.J. Human respiratory syncytial virus nucleoprotein and inclusion bodies antagonize the innate immune response mediated by MDA5 and MAVS. J Virol 2012, 86:8245-8258.
84. Santiago F.W., Covaleda L.M., Sanchez-Aparicio M.T., Silvas J.A., Diaz-Vizarreta A.C., Patel J.R., et al. Hijacking of RIG-I signaling proteins into virus-induced cytoplasmic structures correlates with the inhibition of Type I interferon responses. J Virol 2014, 88:4572-4585.
85. Wu X., Qi X., Qu B., Zhang Z., Liang M., Li C., et al. Evasion of antiviral immunity through sequestering of TBK1/IKKepsilon/IRF3 into viral inclusion bodies. J Virol 2014, 88:3067-3076.
86. Goswami R., Majumdar T., Dhar J., Chattopadhyay S., Bandyopadhyay S.K., Verbovetskaya V., et al. Viral degradasome hijacks mitochondria to suppress innate immunity. Cell Res 2013, 23:1025-1042.
87. Graef K.M., Vreede F.T., Lau Y.F., McCall A.W., Carr S.M., Subbarao K., et al. The PB2 subunit of the influenza virus RNA polymerase affects virulence by interacting with the mitochondrial antiviral signaling protein and inhibiting expression of beta interferon. J Virol 2010, 84:8433-8445.
88. Iwai A., Shiozaki T., Kawai T., Akira S., Kawaoka Y., Takada A., et al. Influenza A virus polymerase inhibits type I interferon induction by binding to interferon beta promoter stimulator 1. J Biol Chem 2010, 285:32064-32074.
89. Dudek S.E., Wixler L., Nordhoff C., Nordmann A., Anhlan D., Wixler V., et al. The influenza virus PB1-F2 protein has interferon antagonistic activity. Biol Chem 2011, 392:1135-1144.
90. Reis A.L., McCauley J.W. The influenza virus protein PB1-F2 interacts with IKKbeta and modulates NF-kappaB signalling. PLoS ONE 2013, 8:e63852.
91. Varga Z.T., Ramos I., Hai R., Schmolke M., Garcia-Sastre A., Fernandez-Sesma A., et al. The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein. PLoS Pathogens 2011, 7:e1002067.
92. Brzozka K., Finke S., Conzelmann K.K. Identification of the rabies virus alpha/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3. J Virol 2005, 79:7673-7681.
93. Cimica V., Dalrymple N.A., Roth E., Nasonov A., Mackow E.R. An innate immunity-regulating virulence determinant is uniquely encoded by the Andes virus nucleocapsid protein. mBio 2014, 5.
94. Lu L.L., Puri M., Horvath C.M., Sen G.C. Select paramyxoviral V proteins inhibit IRF3 activation by acting as alternative substrates for inhibitor of kappaB kinase epsilon (IKKe)/TBK1. J Biol Chem 2008, 283:14269-14276.
95. Matthys V.S., Cimica V., Dalrymple N.A., Glennon N.B., Bianco C., Mackow E.R. Hantavirus GnT elements mediate TRAF3 binding and inhibit RIG-I/TBK1-directed beta interferon transcription by blocking IRF3 phosphorylation. J Virol 2014, 88:2246-2259.
96. Pythoud C., Rodrigo W.W., Pasqual G., Rothenberger S., Martinez-Sobrido L., de la Torre J.C., et al. Arenavirus nucleoprotein targets interferon regulatory factor-activating kinase IKKepsilon. J Virol 2012, 86:7728-7738.
97. Unterstab G., Ludwig S., Anton A., Planz O., Dauber B., Krappmann D., et al. Viral targeting of the interferon-{beta}-inducing Traf family member-associated NF-{kappa}B activator (TANK)-binding kinase-1. Proc Natl Acad Sci U S A 2005, 102:13640-13645.
98. Chang T.H., Kubota T., Matsuoka M., Jones S., Bradfute S.B., Bray M., et al. Ebola Zaire virus blocks type I interferon production by exploiting the host SUMO modification machinery. PLoS Pathogens 2009, 5:e1000493.
99. Buettner N., Vogt C., Martinez-Sobrido L., Weber F., Waibler Z., Kochs G. Thogoto virus ML protein is a potent inhibitor of the interferon regulatory factor-7 transcription factor. J Gen Virol 2010, 91:220-227.
100. Vogt C., Preuss E., Mayer D., Weber F., Schwemmle M., Kochs G. The interferon antagonist ML protein of thogoto virus targets general transcription factor IIB. J Virol 2008, 82:11446-11453.
101. Irie T., Kiyotani K., Igarashi T., Yoshida A., Sakaguchi T. Inhibition of interferon regulatory factor 3 activation by paramyxovirus V protein. J Virol 2012, 86:7136-7145.
102. Shaw M.L., Cardenas W.B., Zamarin D., Palese P., Basler C.F. Nuclear localization of the Nipah virus W protein allows for inhibition of both virus- and toll-like receptor 3-triggered signaling pathways. J Virol 2005, 79:6078-6088.
103. Le May N., Mansuroglu Z., Leger P., Josse T., Blot G., Billecocq A., et al. A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells. PLoS Pathogens 2008, 4:e13.
104. Langland J.O., Cameron J.M., Heck M.C., Jancovich J.K., Jacobs B.L. Inhibition of PKR by RNA and DNA viruses. Virus Res 2006, 119:100-110.
105. Blakqori G., Delhaye S., Habjan M., Blair C.D., Sanchez-Vargas I., Olson K.E., et al. La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts. J Virol 2007, 81:4991-4999.
106. Bouloy M., Janzen C., Vialat P., Khun H., Pavlovic J., Huerre M., et al. Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs. J Virol 2001, 75:1371-1377.
107. Stojdl D.F., Lichty B.D., tenOever B.R., Paterson J.M., Power A.T., Knowles S., et al. VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer Cell 2003, 4:263-275.
108. Marcus P.I., Rojek J.M., Sekellick M.J. Interferon induction and/or production and its suppression by influenza A viruses. J Virol 2005, 79:2880-2890.
109. Jagger B.W., Wise H.M., Kash J.C., Walters K.A., Wills N.M., Xiao Y.L., et al. An overlapping protein-coding region in influenza A virus segment 3 modulates the host response. Science 2012, 337:199-204.
110. Rajani K.R., Pettit Kneller E.L., McKenzie M.O., Horita D.A., Chou J.W., Lyles D.S. Complexes of vesicular stomatitis virus matrix protein with host Rae1 and Nup98 involved in inhibition of host transcription. PLoS Pathogens 2012, 8:e1002929.
111. Le May N., Dubaele S., De Santis L.P., Billecocq A., Bouloy M., Egly J.M. TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus. Cell 2004, 116:541-550.
112. Kainulainen M., Habjan M., Hubel P., Busch L., Lau S., Colinge J., et al. Virulence factor NSs of rift valley fever virus recruits the F-box protein FBXO3 to degrade subunit p62 of general transcription factor TFIIH. J Virol 2014, 88:3464-3473.
113. Kalveram B., Lihoradova O., Ikegami T. NSs protein of rift valley fever virus promotes posttranslational downregulation of the TFIIH subunit p62. J Virol 2011, 85:6234-6243.
114. Thomas D., Blakqori G., Wagner V., Banholzer M., Kessler N., Elliott R.M., et al. Inhibition of RNA polymerase II phosphorylation by a viral interferon antagonist. J Biol Chem 2004, 279:31471-31477.
115. Verbruggen P., Ruf M., Blakqori G., Overby A.K., Heidemann M., Eick D., et al. Interferon antagonist NSs of La Crosse virus triggers a DNA damage response-like degradation of transcribing RNA polymerase II. J Biol Chem 2011, 286:3681-3692.
116. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004, 5:730-737.
117. Kok K.H., Lui P.Y., Ng M.H., Siu K.L., Au S.W., Jin D.Y. The double-stranded RNA-binding protein PACT functions as a cellular activator of RIG-I to facilitate innate antiviral response. Cell Host Microbe 2011, 9:299-309.
118. Malathi K., Dong B., Gale M., Silverman R.H. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 2007, 448:816-819.
119. Yoo J.S., Takahasi K., Ng C.S., Ouda R., Onomoto K., Yoneyama M., et al. DHX36 enhances RIG-I signaling by facilitating PKR-mediated antiviral stress granule formation. PLoS Pathogens 2014, 10:e1004012.